MoneyWorks4Me

The revenue zoomed 12.26% to Rs. 25360.00 millions for the quarter ended March 2025 as compared to Rs. 22590.00 millions during the corresponding quarter last year.An average growth of 25.61% was recorded for the quarter ended March 2025 to Rs. 6670.00  millions from Rs. 5310.00 millions.The company reported a good operating profit of 9680.00 millions compared to 7960.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 25360.00 22590.00 12.26 91980.00 76650.00 20.00 91980.00 76650.00 20.00
Other Income 870.00 790.00 10.13 3520.00 3370.00 4.45 3520.00 3370.00 4.45
PBIDT 9680.00 7960.00 21.61 33310.00 25110.00 32.66 33310.00 25110.00 32.66
Interest 0.00 20.00 0.00 10.00 30.00 -66.67 10.00 30.00 -66.67
PBDT 9680.00 7940.00 21.91 33300.00 25080.00 32.78 33300.00 25080.00 32.78
Depreciation 1070.00 940.00 13.83 4010.00 3760.00 6.65 4010.00 3760.00 6.65
PBT 8610.00 7000.00 23.00 29290.00 21320.00 37.38 29290.00 21320.00 37.38
TAX 1940.00 1690.00 14.79 7200.00 5560.00 29.50 7200.00 5560.00 29.50
Deferred Tax -310.00 100.00 -410.00 -730.00 450.00 -262.22 -730.00 450.00 -262.22
PAT 6670.00 5310.00 25.61 22090.00 15760.00 40.16 22090.00 15760.00 40.16
Equity 530.00 530.00 0.00 530.00 530.00 0.00 530.00 530.00 0.00
PBIDTM(%) 38.17 35.24 8.33 36.21 32.76 10.55 36.21 32.76 10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..